Linktree's latest move: acquiring competitor Koji

Australia-based link-in-bio platform, Linktree, has successfully acquired its competitor, Koji. The latter, owned by GoMeta, was purchased for an undisclosed sum. As part of this acquisition, the Koji link-in-bio product will cease its operations by January 31, 2024.

• Migration Plan: Koji users are being offered a three-month trial of the Linktree Pro plan as part of their transition. However, there's currently no clarity on whether Linktree will be providing tools to assist creators in moving their Koji data.

• Community Integration: Linktree looks forward to welcoming Koji users into their community and is eager to continue innovating in the link-in-bio space. They pledge to closely work with their existing user base and new 'linkers' from Koji in order to cater to their needs and evolve their service offerings.

• Team Integration: There's no official word yet on whether the Koji team will be joining Linktree.

• Koji's Journey: Founded by Dmitry Shapiro and Sean Thielen in 2016, Koji was launched as a link-in-bio platform in March 2021. It has served over 700,000 creators on its platform and raised $36M through its parent entity, GoMeta.

• Linktree's Expansion Plans: This acquisition marks Linktree's second in the link-in-bio space this year, following their procurement of Sequoia-backed link-in-bio startup Bento in June.

With over $165M in funding, Linktree boasts 41 million users worldwide. It's continuously expanding its integrations with various social networks and exploring new monetization options, such as "Buy me a gift." It has also partnered with SendOwl, providing creators an easy way to sell a variety of products and services.